News
 

The novel, orally administered calcitonin gene-related peptide (CGRP) antagonist atogepant has met the primary endpoint

During this Summer we have extended our consultation hours to Wednesdays and Fridays in order to provide better care and reduce waiting lists caused by confinement.

In the last number of Neurology®, a team representing the Aspirin in Reducing Events in the Elderly (ASPREE) study reports the cognitive outcomes from low-dose aspirin (100 mg/d) therapy vs placebo in elderly individuals who were free of cardiovascular disease, physical disability, or diagnosed dementia.

Alzheimer's disease can present clinically with either the typical amnestic phenotype or with atypical phenotypes, such as logopenic progressive aphasia and posterior cortical atrophy.

Trials have evaluated the use of clopidogrel and aspirin to prevent stroke after an ischemic stroke or transient ischemic attack (TIA). In a previous trial, ticagrelor was not better than aspirin in preventing vascular events or death after stroke or TIA.

In this new article the authors (Kristina Szabo et al. https://doi.org/10.1212/WNL.0000000000009783) analyze how the evidence of hippocampal diffusion-weighted imaging (DWI) lesions may support the clinical diagnosis of transient global amnesia (TGA).

Two early studies are raising hopes that some genetic forms of amyotrophic lateral sclerosis (ALS) can be treated.

Low to moderate alcohol consumption is associated with better cognitive function and slower cognitive decline in middle-aged and older adults, new research suggests.

The association between sleep and overall health and well-being has long been of interest to physicians, researchers, and the general public. At the highest level, a simple U-shaped association between total sleep time and mortality has been described from as early as 1964. Those who sleep approximately 7 hours are at the lowest point in the curve,...

Matrix metalloproteinases (MMP)-9 facilitates the migration of T-cells to central nervous system (CNS), while tissue inhibitor of metalloproteinases-1(TIMP-1) inhibits the function of MMP-9.